EMA Issues New Guideline on RSV Products

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency published a new draft guideline on developing medicines and vaccines against respiratory syncytial virus infections, including monoclonal antibodies and direct-acting antivirals.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor